ROGER DANSEY - 21 May 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Roger Dansey
Issuer symbol
INO
Transactions as of
21 May 2024
Net transactions value
$0
Form type
4
Filing time
22 May 2024, 16:49:53 UTC
Previous filing
16 May 2024
Next filing
26 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Award $0 +2,917 $0.000000 2,917 21 May 2024 Common Stock 2,917 $10.99 Direct F1, F2
transaction INO Restricted Stock Unit Award $0 +2,167 $0.000000 2,167 21 May 2024 Common Stock 2,167 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
F2 Options to vest 100% on May 21, 2025.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 21, 2025.